Andrew Gengos

Andrew Gengos

Director of Finance/CFO at TERNS PHARMACEUTICALS, INC.

Net worth: 52 000 $ as of 31/05/2026

61 year
Health Technology
Commercial Services
Finance

Profile

Andrew W.
Gengos
is currently Director at Turn Therapeutics (TM), Inc., Independent Director at Turn Therapeutics, Inc. since 2020, Director at Seneca Therapeutics, Inc. starting 2025, and Chief Financial & Accounting Officer at Terns Pharmaceuticals, Inc. starting 2025.
Former positions include President, Chief Executive Officer & Director at ImmunoCellular Therapeutics Ltd. from 2012 to 2016; President, Chief Executive Officer & Director at Neuraltus Pharmaceuticals, Inc. from 2010 to 2012; Director at Allozyne, Inc.; Vice President-Strategy & Corporate Development at Amgen, Inc. from 2002 to 2010; Vice President-Strategy & Development at Chiron Corp.
in 2010; Chief Financial & Business Officer at Dynavax Technologies Corp.; Senior Manager-Engagement at McKinsey & Co., Inc. from 1991 to 1998; Vice President-Strategy & Corporate Development at Relypsa, Inc. in 2010; Chief Business Officer at Cyteir Therapeutics, Inc. from 2020 to 2023; COO & Head-Corporate Development at Synlogic, Inc. from 2017 to 2018; Chief Financial & Business Officer at AOBiome Therapeutics, Inc. in 2019; and Chief Financial & Business Officer at LeonaBio, Inc. from 2023 to 2024.
Education includes undergraduate studies at Massachusetts Institute of Technology and an MBA from UCLA Anderson School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 10,000 ( 0.03% ) 52 000 $ 31/05/2026

Andrew Gengos active positions

CompaniesPositionStart
TERNS PHARMACEUTICALS, INC. Director of Finance/CFO 24/02/2025
TURN THERAPEUTICS INC. Director/Board Member 01/01/2020
Director/Board Member -
Director/Board Member 01/03/2025

Former positions of Andrew Gengos

CompaniesPositionEnd
LEONABIO, INC. Director of Finance/CFO 01/10/2024
CYTEIR THERAPEUTICS, INC. Corporate Officer/Principal 03/02/2023
Director of Finance/CFO 01/12/2019
SYNLOGIC, INC. Chief Operating Officer 01/12/2018
EOM PHARMACEUTICALS HOLDINGS, INC. Chief Executive Officer 01/12/2016
See the detail of Andrew Gengos's experience

Training of Andrew Gengos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

93

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!